For Research Purposes Only — This compound is not FDA approved.

A synthetic heptapeptide analog of tuftsin, studied for anxiolytic and neuroimmune signaling pathways in research models. Premium Research Peptide.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and a molecular weight of 751.9 g/mol. Its first four residues are tuftsin, a tetrapeptide released from the heavy chain of immunoglobulin G and studied since the 1970s for its effects on phagocytic cells. Tuftsin is destroyed quickly by peptidases, and the Pro-Gly-Pro extension was added to give a more stable molecule to work with.
Like Semax, which carries the same three-residue tail, Selank was developed in Russia, and the primary literature is concentrated in a small number of Russian institutes. Readers should expect animal and cell studies in the main, with limited independent replication elsewhere.
Selank is registered as a medicine in Russia. It is not approved by the FDA or the EMA, and this research-grade material is not a pharmaceutical product. It is supplied for in vitro and laboratory research only and is not for human or veterinary use. The Selank research guide covers the literature in more depth.
The Certificate of Analysis above reports HPLC-UV purity, LC-MS identity and net peptide content. For a short, basic peptide the third deserves particular attention. Selank has two positively charged side chains, lysine and arginine, as well as a free N-terminus, and each carries a counter-ion in the solid state. Together with bound water, those counter-ions make up a real fraction of the powder mass, so the weight of peptide in a vial is always lower than the weight of powder. Net peptide content is the measurement that accounts for this, and it is the number to use when preparing a solution of known concentration. LC-MS identity confirms the mass of the heptapeptide and distinguishes it from truncated species such as tuftsin itself. See how to read a Certificate of Analysis and HPLC vs mass spectrometry.
Chemically, Selank is one of the more forgiving peptides in the catalogue: its sequence has no methionine, cysteine or tryptophan, the residues most prone to oxidation. Its practical weakness is water. The powder is hygroscopic, and a vial opened cold will collect condensation, so let it reach room temperature first and reseal promptly. It dissolves readily in aqueous solvent with gentle swirling. Keep the lyophilised powder frozen and dry, refrigerate solutions, and aliquot a stock into single-use volumes instead of freezing and thawing it. See peptide storage and stability and how to reconstitute a research peptide.
Thr-Lys-Pro-Arg-Pro-Gly-Pro, seven amino acids, with a molecular weight of 751.9 g/mol and CAS number 129954-34-3.
The first four residues of Selank, Thr-Lys-Pro-Arg, are the tetrapeptide tuftsin. A Pro-Gly-Pro tail was added to make the molecule more resistant to enzymatic breakdown.
No. Selank is registered as a medicine in Russia but is not approved by the FDA or the EMA. This material is research grade, for in vitro and laboratory use only, and is not for human or veterinary use.
Both are heptapeptides ending in Pro-Gly-Pro, but the active portions differ. Selank begins with the tuftsin sequence, while Semax begins with a fragment of ACTH. They are distinct compounds with separate literatures.
Keep the lyophilised powder at -20 C, dry and protected from light, and let the vial warm to room temperature before opening because the powder is hygroscopic. After reconstitution store at 2-8 C in single-use aliquots.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, you confirm that you are a qualified researcher and will use these products in accordance with all applicable laws and regulations.